Quality of life and pain control following laparoscopic retroperitoneal lymph node dissection in early-stage nonseminoma

Nicola Nicolai, Elisabetta Bianchi, Ilaria Donati, Camilla L'Acqua, Cinzia Brunelli, Davide Biasoni, Mario Catanzaro, Silvia Stagni, Luigi Piva, Tullio Torelli, Andrea Necchi, Daniele Raggi, Patrizia Giannatempo, Elena Faré, Maurizio Colecchia, Martin Langer, Claudia Borreani, Roberto Salvioni

Research output: Contribution to journalArticle

Abstract

Aims and background: To evaluate postoperative pain (PoP) and quality of life (QoL) in patients undergoing open (O-) or laparoscopic (L-) retroperitoneal lymph node dissection (RPLND) for clinical stage I (CS I) and normal markers CS IIA nonseminomatous germ cell tumors. Methods: Since March 2010, a prospective nonrandomized trial evaluated dynamic and rest (R) numeric pain scale (NPS) following patient-controlled analgesia and baseline (T0), 3-month (T3), and 6-month (T6) QoL status assessed by Functional Assessment of Cancer Therapy-General (FACT-G) questionnaire and the Italian-validated Functional Assessment of Chronic Illness Therapy (FACT-T-SG) at T6. Secondary endpoints included length of hospital stay (LHS), interval to recovery (ItR), complications, and oncologic outcomes. Results: In March 2012, 69 (64 CS I) patients were enrolled. Five patients only chose O-RPLND. The PoP and complete QoL data are available in 41 and 56 patients, respectively. The R-NPS significantly improved in days 1-2 vs day 0 (p

Original languageEnglish
Pages (from-to)650-656
Number of pages7
JournalTumori
Volume101
Issue number6
DOIs
Publication statusPublished - Nov 1 2015

Fingerprint

Lymph Node Excision
Quality of Life
Pain
Postoperative Pain
Length of Stay
Patient-Controlled Analgesia
Chronic Disease
Therapeutics
Neoplasms

Keywords

  • Clinical outcome
  • Germ cell and embryonal
  • Neoplasms
  • Pain management
  • Quality of life
  • Testis neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Quality of life and pain control following laparoscopic retroperitoneal lymph node dissection in early-stage nonseminoma. / Nicolai, Nicola; Bianchi, Elisabetta; Donati, Ilaria; L'Acqua, Camilla; Brunelli, Cinzia; Biasoni, Davide; Catanzaro, Mario; Stagni, Silvia; Piva, Luigi; Torelli, Tullio; Necchi, Andrea; Raggi, Daniele; Giannatempo, Patrizia; Faré, Elena; Colecchia, Maurizio; Langer, Martin; Borreani, Claudia; Salvioni, Roberto.

In: Tumori, Vol. 101, No. 6, 01.11.2015, p. 650-656.

Research output: Contribution to journalArticle

@article{faace2753d2b45beb2cc4348d586bfbc,
title = "Quality of life and pain control following laparoscopic retroperitoneal lymph node dissection in early-stage nonseminoma",
abstract = "Aims and background: To evaluate postoperative pain (PoP) and quality of life (QoL) in patients undergoing open (O-) or laparoscopic (L-) retroperitoneal lymph node dissection (RPLND) for clinical stage I (CS I) and normal markers CS IIA nonseminomatous germ cell tumors. Methods: Since March 2010, a prospective nonrandomized trial evaluated dynamic and rest (R) numeric pain scale (NPS) following patient-controlled analgesia and baseline (T0), 3-month (T3), and 6-month (T6) QoL status assessed by Functional Assessment of Cancer Therapy-General (FACT-G) questionnaire and the Italian-validated Functional Assessment of Chronic Illness Therapy (FACT-T-SG) at T6. Secondary endpoints included length of hospital stay (LHS), interval to recovery (ItR), complications, and oncologic outcomes. Results: In March 2012, 69 (64 CS I) patients were enrolled. Five patients only chose O-RPLND. The PoP and complete QoL data are available in 41 and 56 patients, respectively. The R-NPS significantly improved in days 1-2 vs day 0 (p",
keywords = "Clinical outcome, Germ cell and embryonal, Neoplasms, Pain management, Quality of life, Testis neoplasms",
author = "Nicola Nicolai and Elisabetta Bianchi and Ilaria Donati and Camilla L'Acqua and Cinzia Brunelli and Davide Biasoni and Mario Catanzaro and Silvia Stagni and Luigi Piva and Tullio Torelli and Andrea Necchi and Daniele Raggi and Patrizia Giannatempo and Elena Far{\'e} and Maurizio Colecchia and Martin Langer and Claudia Borreani and Roberto Salvioni",
year = "2015",
month = "11",
day = "1",
doi = "10.5301/tj.5000354",
language = "English",
volume = "101",
pages = "650--656",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "6",

}

TY - JOUR

T1 - Quality of life and pain control following laparoscopic retroperitoneal lymph node dissection in early-stage nonseminoma

AU - Nicolai, Nicola

AU - Bianchi, Elisabetta

AU - Donati, Ilaria

AU - L'Acqua, Camilla

AU - Brunelli, Cinzia

AU - Biasoni, Davide

AU - Catanzaro, Mario

AU - Stagni, Silvia

AU - Piva, Luigi

AU - Torelli, Tullio

AU - Necchi, Andrea

AU - Raggi, Daniele

AU - Giannatempo, Patrizia

AU - Faré, Elena

AU - Colecchia, Maurizio

AU - Langer, Martin

AU - Borreani, Claudia

AU - Salvioni, Roberto

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Aims and background: To evaluate postoperative pain (PoP) and quality of life (QoL) in patients undergoing open (O-) or laparoscopic (L-) retroperitoneal lymph node dissection (RPLND) for clinical stage I (CS I) and normal markers CS IIA nonseminomatous germ cell tumors. Methods: Since March 2010, a prospective nonrandomized trial evaluated dynamic and rest (R) numeric pain scale (NPS) following patient-controlled analgesia and baseline (T0), 3-month (T3), and 6-month (T6) QoL status assessed by Functional Assessment of Cancer Therapy-General (FACT-G) questionnaire and the Italian-validated Functional Assessment of Chronic Illness Therapy (FACT-T-SG) at T6. Secondary endpoints included length of hospital stay (LHS), interval to recovery (ItR), complications, and oncologic outcomes. Results: In March 2012, 69 (64 CS I) patients were enrolled. Five patients only chose O-RPLND. The PoP and complete QoL data are available in 41 and 56 patients, respectively. The R-NPS significantly improved in days 1-2 vs day 0 (p

AB - Aims and background: To evaluate postoperative pain (PoP) and quality of life (QoL) in patients undergoing open (O-) or laparoscopic (L-) retroperitoneal lymph node dissection (RPLND) for clinical stage I (CS I) and normal markers CS IIA nonseminomatous germ cell tumors. Methods: Since March 2010, a prospective nonrandomized trial evaluated dynamic and rest (R) numeric pain scale (NPS) following patient-controlled analgesia and baseline (T0), 3-month (T3), and 6-month (T6) QoL status assessed by Functional Assessment of Cancer Therapy-General (FACT-G) questionnaire and the Italian-validated Functional Assessment of Chronic Illness Therapy (FACT-T-SG) at T6. Secondary endpoints included length of hospital stay (LHS), interval to recovery (ItR), complications, and oncologic outcomes. Results: In March 2012, 69 (64 CS I) patients were enrolled. Five patients only chose O-RPLND. The PoP and complete QoL data are available in 41 and 56 patients, respectively. The R-NPS significantly improved in days 1-2 vs day 0 (p

KW - Clinical outcome

KW - Germ cell and embryonal

KW - Neoplasms

KW - Pain management

KW - Quality of life

KW - Testis neoplasms

UR - http://www.scopus.com/inward/record.url?scp=84949441925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949441925&partnerID=8YFLogxK

U2 - 10.5301/tj.5000354

DO - 10.5301/tj.5000354

M3 - Article

C2 - 26045105

AN - SCOPUS:84949441925

VL - 101

SP - 650

EP - 656

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 6

ER -